The Journal of Korean Diabetes

Search

Page Path

HOME
Search

Statement

2형당뇨병 관리 패러다임 변화: 혈당강하 대 기관보호: 원종철; J Korean Diabetes. 2023;24(2):59-65. Published online June 30, 2023; DOI: https://doi.org/10.4093/jkd.2023.24.2.59

2022년 미국ㆍ유럽당뇨병학회 공동합의안과 2023년 미국당뇨병학회 권고안 요약: 2형당뇨병 환자의 혈당관리: 서미혜; J Korean Diabetes. 2023;24(1):5-11. Published online March 30, 2023; DOI: https://doi.org/10.4093/jkd.2023.24.1.5

Opinion

당뇨병 약제의 역할은 어디까지인가?: 홍준화; J Korean Diabetes. 2022;23(3):153-156. Published online September 30, 2022; DOI: https://doi.org/10.4093/jkd.2022.23.3.153

Case Report

소적혈구성 빈혈을 동반한 2형당뇨병 환자에서 진단된 무세룰로플라스민혈증: 박범균, 유은애, 박효숙, 김지혜; J Korean Diabetes. 2022;23(2):144-152. Published online June 30, 2022; DOI: https://doi.org/10.4093/jkd.2022.23.2.144

Original Article

국내 종합병원의 2형당뇨병 환자의 당뇨병관리 실태: 5년 추적 연구: 정진희, 이정화, 장향미, 나영, 최희선, 이연희, 강양교, 김나래, 이정림, 송복례, 심강희; J Korean Diabetes. 2022;23(1):64-75. Published online March 31, 2022; DOI: https://doi.org/10.4093/jkd.2022.23.1.64

Focused Issues

혈압변동성과 당뇨병: 정채호, 손태서; J Korean Diabetes. 2022;23(1):21-27. Published online March 31, 2022; DOI: https://doi.org/10.4093/jkd.2022.23.1.21

Statement

마이크로바이옴, 그리고 당뇨병: 김진화; J Korean Diabetes. 2022;23(1):7-11. Published online March 31, 2022; DOI: https://doi.org/10.4093/jkd.2022.23.1.7

Focused Issues

2021 당뇨병 진료지침: 심혈관질환 위험관리: 문민경; J Korean Diabetes. 2021;22(4):259-267. Published online December 31, 2021; DOI: https://doi.org/10.4093/jkd.2021.22.4.259
Cited By 1

Original Article

2형당뇨병 환자에서 인슐린저항성과 염증이 동반질환에 미치는 병합효과: 김은정, 이은영, 이용호, 최영주, 박석원, 이은직, 이현철, 허갑범; J Korean Diabetes. 2021;22(3):207-219. Published online September 30, 2021; DOI: https://doi.org/10.4093/jkd.2021.22.3.207

Information Desks

심리적 인슐린저항성의 영향요인 및 극복 방법: 장연정; J Korean Diabetes. 2021;22(3):192-196. Published online September 30, 2021; DOI: https://doi.org/10.4093/jkd.2021.22.3.192
Cited By 2

Case Report

2형당뇨병 환자에서 혈당조절 악화의 임상양상으로 나타난 자가면역성 췌장염 1예: 김선희, 백초옥, 송선경, 김지혜; J Korean Diabetes. 2021;22(2):153-159. Published online June 30, 2021; DOI: https://doi.org/10.4093/jkd.2021.22.2.153

Focused Issues

Sodium Glucose Cotransporter-2 억제제의 최신지견: 조동혁; J Korean Diabetes. 2021;22(2):113-125. Published online June 30, 2021; DOI: https://doi.org/10.4093/jkd.2021.22.2.113

설포닐유레아 최신지견: 김태년; J Korean Diabetes. 2021;22(2):105-112. Published online June 30, 2021; DOI: https://doi.org/10.4093/jkd.2021.22.2.105
Cited By 1

Thiazolidinedione 최신지견: 김원준; J Korean Diabetes. 2021;22(2):97-104. Published online June 30, 2021; DOI: https://doi.org/10.4093/jkd.2021.22.2.97
Cited By 1

Dipeptidyl Peptidase 4 억제제 최신지견: 이주희; J Korean Diabetes. 2021;22(2):91-96. Published online June 30, 2021; DOI: https://doi.org/10.4093/jkd.2021.22.2.91

Volume 24, No. 2

The Journal of
Korean Diabetes

Print ISSN: 2233-7431
Online ISSN: 2714-0547

MOST VIEWED

2,955	Recent Advances in Anti-Obesity Drugs
1,073	Summary: Management of Hyperglycemia in Type 2 Diabetes according to the 2022 ADA-EASD Consensus Report and 2023 ADA Standards of Care in Diabetes
2,432	Use of Dual-Energy X-ray Absorptiometry for Body Composition in Chronic Disease Management
973	Revisiting the Diabetes Crisis in Korea: Call for Urgent Action
2,601	Glycemic Variability and Diabetes Mellitus

Editorial Office: 101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-714-9064 Fax: +82-2-714-9084 E-mail: diabetes@kams.or.kr

Copyright © 2023 by Korean Diabetes Association. All rights reserved.